adrenal incidentaloma work up and management
play

Adrenal Incidentaloma: Work up and Management No Conflicts to - PowerPoint PPT Presentation

Adrenal Incidentaloma: Work up and Management No Conflicts to Declare Quan-Yang Duh Professor of Surgery University of California, San Francisco UCSF Postgraduate Course in Endocrine & Breast Surgery March 6, 2015 Surgical Approach to


  1. Adrenal Incidentaloma: Work up and Management No Conflicts to Declare Quan-Yang Duh Professor of Surgery University of California, San Francisco UCSF Postgraduate Course in Endocrine & Breast Surgery March 6, 2015 Surgical Approach to Adrenal “Incidentaloma” Incidentalomas: Objectives � Work up for incidental adrenal tumors “Adrenal incidentalomas are tumours of the adrenal gland that are discovered incidentally � Evaluating and treating functioning tumors when imaging studies are done for purpose � Pheochromocytoma other than searching for adrenal pathology.” � Hypercortisolism and hyperaldosteronism � Evaluating and treating adrenal malignancy 1-5% of abdominal imaging studies identify � metastasis unanticipated adrenal tumor � adrenocortical cancer � Techniques and results of adrenalectomy Geelhoed GW, Druy EM. Surgery 92: 866-874, 1982 Duh QY. Br J Surg 89:1347, 2002 1

  2. (Relative) Contraindications for Indications for Adrenalectomy Laparoscopic Adrenalectomy � Hypersecretion of hormones � Large adrenal tumors � Local symptoms � What is “large”? > 6-15 cm? � Cancers or potential cancers � > 8 cm for right, > 10 cm for left � Uncertain diagnosis � Adrenocortical carcinomas � Not for obviously invasive cancers. � Start laparoscopic then convert as needed? All adrenalectomy can be performed by laparoscopy EXCEPT… � Technical limitations � Risks of inadequate/inappropriate resection (cancer) 500 Laparoscopic Adrenalectomies Most Adrenal Incidentalomas are Non- functioning Adenomas UCSF,1993 to 2009: Diagnoses � Hyperaldosteronism N=161 32% � Patient selection (retrospective, prospective, population based) influences prevalence of � Pheochromocytoma N=117 23% incidentaloma � Cushing N=82 16% � 1% at age 30, 4% at age 60, 7% at age 70 � Cortical tumors N=41 8% � Patient selection also influences the � Metastases N=42 8% prevalence of surgical disease (e.g., � Others N=57 11% functioning or suspicious tumors) � 7-30% of operated, 1-10% of pheos or ACC 2

  3. Swedish Prospective Multicenter Study Western Sweden Adrenal Study Group Population : Incidentaloma for Adrenal Incidentaloma � 381 patients, 33 hospitals, 1996-2001 � Population 1.7 millions, 18 months, 19 radiology Depts, consecutive, prospective � 164 men, 217 women, age 64 (18-84), 3 (1-20) cm � 34,044 scans, 534 assessed (1.6 %) � Operative criteria: � > 3-4 cm or hypersecreting hormone � 226 pts included, 15 operated (6.6%) � 85/381 (22%) operated � 3 aldo, 1 pheo, 1 metastasis � 10 non-functioining large adenoma (>3 cm) � 20 (5%) hypersecreting benign tumors (15 pheos) � No additional disease diagnosed at 2 yr f/u � 14 (4%) malignant (10 adrenal cortical ca) � 10 (4-16) cm Muth A, et al. Br J Sur; 2011;98:1383-91 B Bulow & B Ahren (Lund): J Intern Med. 2002;252:239-46. NIH State-of-the-Science Conference on Biochemical Diagnosis of Pheochromocytoma: Which test is best? the Clinically Inapparent Adrenal Mass � 1-mg Dex suppression � Plasma metanephrines � Plasma free metanephr � Best negative predictive v � Resect all pheo, clinical � More false positives Cushing, aldo and others � Screen familial disease � Surgery or observation for � Urinary metanephrines subclinical Cushing � Best positive predictive v � Resect > 6 cm � Fewer false positives � Observe < 4 cm � All other patients � Q 6 m imaging x 2 � (CT/MRI characteristics) � Q y hormonal study x 4 Lenders et al: JAMA 287: 1427, 2002 NIH Consens State Sci Statements. 2002 Feb 4-6;19(2):1-25 3

  4. Pheochromocytoma: Localizing Studies Germ-line Mutations are Common CT MRI MIBG (not a “10% tumor”, 1/3 hereditary) � If multifocal, 84% � If < 18 year- old, 59% � If Extra- adrenal, 93% � 66/271 (24%) of non-syndromic pheo � 30 VHL, 13 RET, 11 SDHD, 12 SDHB Malignant or metastatic Best for surgical planning Planning for I131 Tx Neumann et al: NEJM 346: 1459, 2002 Pheochromocytoma Crisis Is Not a Cushing’s Syndrome: Surgical Emergency Laboratory Diagnosis � Low-dose dexamethasone suppression � 25 /137 (18%) UCSF pheo presented in crisis � 1 mg dexamethasone PO at 11 PM � Alpha-adrenergic blockade at least 10 days � 8 AM plasma cortisol (nl < 5 mcg/dL vs 1.8) � 10 urgent, 15 elective, no emergency operation � Mid-night salivary cortisol level � No death � normal < 550 ng/dL � 24 hr urine free cortisol � 33/97 pheo crisis pts had emergency operations � Central obesity � nl 5-50 mcg/24 hr � Death 6/33 vs 0/64 (emergent vs urgent/elective) � Moon facies � Plasma ACTH � Intraop complications 80% vs 42% � Supraclavicular � “Subclinical Cushing’s” � Postop complications 71% vs 33 % fat pad � Dexamethasone not suppressible � Purple Striae � Post resection Addisonian crisis Scholten, et al: J Clin Endocrinol Metab 98:581-591, 2013. Shen WT, et al: Arch Surg.141:771, 2006 4

  5. Incidentaloma with Subclinical Cushing’s Aldosteronoma: CT scan Resect or Observe? � 1- 2 cm � Randomized, 45 patients, 7.7 (2-15) years, Padua. � Incidentaloma < 3.5 cm, no overt disease, but � No contralateral abnl abnormal Dex-suppression. � Adrenal protocol � 23 Lap adrenalectomy � Diabetes : 62.5% (5/8) normalized or improved � Without and with contrast � Hypertension: 67% (12/18) � Thin cut (2.5 mm or less) � Hyperlipidemia: 37.5% (3/8) � Low Hounsfield U � Obesity: 50% (3/6) � Osteoporosis did not improve. � < 10 pre-contrast � 22 Non-surgical: No improvement � Early washout of � 3 crossed over to adrenalectomy (tumor grew to > 3.5 cm) contrast Toniato A, et al: Ann Surg 249:388-391, 2009 Laboratory Diagnosis: 1 o hyperaldo Role of Adrenal Vein Sampling � High plasma aldosterone (PA) � If relying on CT scan alone � > 20 ng/dL (adenoma), 12-20 (hyperplasia) � 22% would have been exclude for adrenalectomy � off meds (spironolactone, diuretic, ACE inhibitors, etc) (bilateral normal or bilateral nodular) � on high salt diet (>120 mEq/d x 4d) � Low plasma renin activity (PRA) � 25% would have unnecessary or inappropriate � < 0.5 ng/ml/hr (wrong side) adrenalectomy � High PA/PRA ratio (> 20-30) � “AVS is an essential diagnostic step in most � Adenomas higher (25-100), hyperplasia (15-25) patients to distinguish between unilateral and � Elevated 24 hour urinary aldosterone bilateral adrenal aldosterone hypersecretion” � Less commonly used WF Young, et al. Surgery 136:1227, 2004 Founders JW, et al. JCEM 93:3266, 2008 5

  6. A Clinical Prediction Score to Diagnose Incidentaloma: Unilateral Primary Aldosteronism Avoid FNA � 100% specific for APA if typical adenoma � Mayo clinic, 1995- >0.8 cm and K < 3.5 or Cr Clr >100 2005, 20 FNA � 14 complications � 6 hematoma � 5 incorrect dx � 2 recurrences Vanderveen KA, et al (Thompson GB), Surgery; 2009; 146:1158-66 Kupers EM, et al. J Clin Endocrinol Metab 97:3530-7, 2012 Adrenal Incidentaloma as Presentation of Resection for Isolated Adrenal Metastasis Unknown Primary Cancer is very Rare � MSK 1995-2006 � Retrospective review 1715 patients referred for evaluation of suspected unknown primary � Median survival 30 months cancer,1639 had cancer. � 17% local recurrence � Adrenal involved at presentation in 95 (5.8%). � 31 lap vs. 63 open � Op time: 175 min vs. 208 min � Involved only adrenal in 4 patients (0.2%). � EBL: 106 ml vs 749 ml � All large (> 6 cm), symptomatic, 3/4 bilateral. � Hosp: 2.8 d vs. 8.0 d � NO TURE INCIDENTALOMA � Fewer complications Strong VE, et al. Ann Surg Oncol 14: 3392, 2007 Lee J, et al (MD Anderson): Surgery 1998; 124:1115-22. Duh QY. Ann Surg Oncol 14:3288, 2007 6

  7. Is size the best Predictor for the risk of Adrenocortical Carcinoma: Imaging Adrenal Cortical Cancer? 30% � CT findings � Central necrosis � Cortical adenoma 25% � Irregularity � Homogeneous 20% � HU > 20 � Pre-contrast < 10 HU � Rapid wash-out � Invasion (liver, IVC) 15% � Carcinoma, mets, 10% pheochromocytoma � Heterogeneous 5% � Pre-contrast > 20 HU � Slow wash-out 0% < 4 cm 4-6 cm > 6 cm NIH Consens State Sci Statements. 2002 Feb 4-6;19(2):1-25 Laparoscopic compared to Open Laparoscopic Adrenalectomy: Size Matters (UCSF, 1993-2011) Adrenalectomy: more positive margin and tumor rupture, earlier recurrence � 523 patients, 563 adrenalectomies � Aldo180, pheo 123, Cushing 85, mets 44, others 91 � Smaller (< 3 cm) vs Larger ( ≥ 3 cm) tumors � op time 2.29 hr vs 3.07 hr � EBL 44 ml vs 97 ml � Intraop complication 2% vs 10% � Postop complications 14% vs 24 % � Hospital stay 1.6 days vs 2.5 days Miller BS, et al: World J Surg 34:1380-1385, 2010. 7

  8. Management of Adrenal Bilateral Incidentalomas Incidentalomas � 15-20% of � Work up of adrenal tumors incidentalomas � R/O pheo (metanephrines), Cushing (Dex-sup.) � 4 times more � no FNA likely to have � When to operate subclinical � Functioning tumors, isolated metastases Cushing � Large (> 5-6 cm) and increased risk of cancer � 4 times less � How to operate likely to have � Laparoscopic (retroperitoneal vs transabdominal) Pheos � Open resection for cancer Pasternak JD, et al: Pacific Coast Surgical Association, 2015 8

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend